Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Market Closed - Nasdaq Other stock markets 21:00:00 07/05/2024 BST			5-day change	1st Jan Change
5.48 ^USD	+13.22%		+15.13%	+29.86%

05-07	Sector Update: Health Care Stocks Advance in Late Afternoon Trading	MT
05-07	Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vanda Pharmaceuticals Inc. Appoints Dr. Tage Honoré to its Board of Directors	17/03/23	CI
Insider Sell: Vanda Pharmaceuticals	07/12/22	MT
H. Thomas Watkins Not Stands for Reelection of Vanda Pharmaceuticals Inc	25/04/22	CI
Insider Sell: Vanda Pharmaceuticals	02/12/21	MT
Vanda Pharmaceuticals Inc. Announces Resignation of Aranthan “Aj” Jones II as the Corporate Affairs and Communications Officer	08/10/21	CI
Insider Sell: Vanda Pharmaceuticals	17/09/21	MT
Insider Sell: Vanda Pharmaceuticals	13/09/21	MT
Insider Trends: 90-Day Insider Buying Trend Scaled Back with Sale of Vanda Pharmaceuticals Shares	27/07/21	MT
Vanda Pharmaceuticals Inc. Announces Resignation of Mihael H. Polymeropoulos as Director	22/04/20	CI
Vanda Pharmaceuticals Inc. Announces Resignation of Gian Piero Reverberi as Senior Vice President and Chief Commercial Officer, Effective as of March 16, 2020	03/03/20	CI
Vanda Pharmaceuticals Inc. Announces Executive Changes, Effective March 15, 2020	20/02/20	CI
Vanda Pharmaceuticals Inc. Announces Board Changes	19/02/20	CI
Vanda Pharmaceuticals Announces Resignation of Gian Piero Reverberi as its Senior Vice President, Chief Commercial Officer, Effective March 16, 2020	21/01/20	CI
Vanda Pharmaceuticals Inc. Hires Scott L. Howell as Its Chief People Officer	06/11/19	CI
Vanda Pharmaceuticals Inc. Appoints Anne Sempowski Ward to Board of Directors	28/10/19	CI
Vanda Pharmaceuticals Announces Management Appointments	21/08/19	CI
Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors	24/04/19	CI
Vanda Pharmaceuticals Inc. Appoints Timothy Williams as Senior Vice President, General Counsel and Secretary	13/08/18	CI
Vanda Pharmaceuticals Inc. Announces Retirement of Kenneth M. Bate from the Board of Directors	25/04/18	CI
Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018	23/04/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Insiders

Filters